State Street Corp Obs Eva Sa Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.34 - $2.08 $1,360 - $2,111	-1,015 Reduced 0.89%	112,977 $182,000
Q1 2022 May 16, 2022	BUY	$1.1 - $2.17 $5,579 - $11,006	5,072 Added 4.66%	113,992 $172,000
Q4 2021 Feb 14, 2022	BUY	$1.99 - $3.1 $3,995 - $6,224	2,008 Added 1.88%	108,920 $217,000
Q3 2021 Nov 15, 2021	BUY	$2.47 - $3.34 $147,157 - $198,990	59,578 Added 125.87%	106,912 $332,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $3.35 $2,841 - $3,718	-1,110 Reduced 2.29%	47,334 $143,000
Q1 2021 May 17, 2021	SELL	$2.01 - $5.05 $6 - $15	-3 Reduced 0.01%	48,444 $157,000
Q4 2020 Feb 16, 2021	SELL	$1.89 - $2.55 $2,923 - $3,944	-1,547 Reduced 3.09%	48,447 $101,000
Q3 2020 Nov 10, 2020	BUY	$2.46 - $6.15 $122,985 - $307,463	49,994 New	49,994 $124,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.